Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/19/2019 06/20/2019 06/21/2019 06/24/2019 06/25/2019 Date
128.16(c) 130.82(c) 130.81(c) 129.57(c) 162.43(c) Last
6 970 879 3 850 083 4 616 582 2 390 112 33 047 499 Volume
+6.23% +2.08% -0.01% -0.95% +25.36% Change
More quotes
Financials (USD)
Sales 2019 15 274 M
EBIT 2019 7 138 M
Net income 2019 -1 911 M
Debt 2019 19 047 M
Yield 2019 2,31%
Sales 2020 15 615 M
EBIT 2020 7 257 M
Net income 2020 1 094 M
Debt 2020 15 308 M
Yield 2020 2,39%
P/E ratio 2019 -
P/E ratio 2020 69,34
EV / Sales2019 4,03x
EV / Sales2020 3,70x
Capitalization 42 473 M
More Financials
Company
Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments:... 
Sector
Pharmaceuticals
Calendar
08/07Earnings Release
More about the company
Surperformance© ratings of Allergan plc
Trading Rating : Investor Rating :
More Ratings
Latest news on ALLERGAN PLC
06/25WeissLaw LLP Investigates Allergan Plc
PR
06/25AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
06/25ALLERGAN PLC : Entry into a Material Definitive Agreement, Regulation FD Disclos..
AQ
06/25MARKET SNAPSHOT: Nasdaq Records Three-day Losing Streak After Powell Emphasiz..
DJ
06/25AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
06/25ABBVIE : S&P Puts AbbVie on Watch Negative After Allergan Deal
DJ
06/25ABBVIE : Agrees to Buy Allergan for More Than $60 Billion--6th Update
DJ
06/25ABBVIE : Agrees to Buy Allergan for More Than $60 Billion--5th Update
DJ
06/25ABBVIE : Agrees to Buy Allergan for More Than $60 Billion--4th Update
DJ
06/25ALLERGAN : Thinking about buying stock in Allergan, Biopharmx, Beyond Meat, Immu..
PR
More news
Analyst Recommendations on ALLERGAN PLC
More recommendations
Sector news : Pharmaceuticals - NEC
06/25AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
06/25Nestlé, Novartis Among Companies at Risk of London Trading Ban -- 2nd Update
DJ
06/25AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
06/25ABBVIE : S&P Puts AbbVie on Watch Negative After Allergan Deal
DJ
06/25Nestlé, Novartis at Risk of London Trading Ban -- Update
DJ
More sector news : Pharmaceuticals - NEC
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 173 $
Spread / Average Target 33%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Wayne R. Swanton Executive Vice President-Global Operations
Matthew M. Walsh Chief Financial Officer & Executive Vice President
C. David Nicholson Chief Research & Development Officer
Charles Hugh-Jones Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC-3.06%40 362
JOHNSON & JOHNSON10.10%348 981
PFIZER0.05%233 072
ROCHE HOLDING LTD.13.50%227 848
NOVARTIS21.44%220 893
MERCK AND COMPANY11.91%206 641